Transcript : CytoDyn Inc. – Special Call

Greetings, and welcome to today’s CytoDyn R&D Investor Update. My name is Diego, and I will serve as your moderator today. [Operator Instructions] As a reminder, this call is being recorded…

S&P Capital IQ 2022

All news about CYTODYN INC.

Sales 2022 0.27 – – Net income 2022 -211 m – – Net Debt 2022 32.6m – – P/E ratio 2022 -1.02x Yield 2022 –

capitalization 277 m 277 m – EV / Sales 2021 – EV / Sales 2022 989 524 989x Nbr of Employees – free float 91.8%

Duration : Auto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax. Period : DayWeek

Income statement evolution